XTANT MEDICAL HLDGS
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety thro… Read more
Market Cap & Net Worth: XTANT MEDICAL HLDGS (XMS)
XTANT MEDICAL HLDGS (F:XMS) has a market capitalization of $76.89 Million (€74.90 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #24489 globally and #2680 in its home market, demonstrating a 7.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying XTANT MEDICAL HLDGS's stock price €0.54 by its total outstanding shares 140004240 (140.00 Million).
XTANT MEDICAL HLDGS Market Cap History: 2018 to 2026
XTANT MEDICAL HLDGS's market capitalization history from 2018 to 2026. Data shows change from $307.54 Million to $76.89 Million (-19.53% CAGR).
XTANT MEDICAL HLDGS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how XTANT MEDICAL HLDGS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of XMS by Market Capitalization
Companies near XTANT MEDICAL HLDGS in the global market cap rankings as of March 18, 2026.
Key companies related to XTANT MEDICAL HLDGS by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
XTANT MEDICAL HLDGS Historical Marketcap From 2018 to 2026
Between 2018 and today, XTANT MEDICAL HLDGS's market cap moved from $307.54 Million to $ 76.89 Million, with a yearly change of -19.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €76.89 Million | -18.94% |
| 2025 | €94.85 Million | +52.07% |
| 2024 | €62.37 Million | -59.81% |
| 2023 | €155.21 Million | +78.51% |
| 2022 | €86.94 Million | +19.80% |
| 2021 | €72.57 Million | -46.56% |
| 2020 | €135.81 Million | -35.71% |
| 2019 | €211.25 Million | -31.31% |
| 2018 | €307.54 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of XTANT MEDICAL HLDGS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $76.89 Million USD |
| MoneyControl | $76.89 Million USD |
| MarketWatch | $76.89 Million USD |
| marketcap.company | $76.89 Million USD |
| Reuters | $76.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.